Gilead Sciences
GILD
GILD
1,515 hedge funds and large institutions have $69.3B invested in Gilead Sciences in 2017 Q2 according to their latest regulatory filings, with 105 funds opening new positions, 588 increasing their positions, 662 reducing their positions, and 93 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% less funds holding
Funds holding: 1,520 → 1,515 (-5)
11% less repeat investments, than reductions
Existing positions increased: 588 | Existing positions reduced: 662
28% less call options, than puts
Call options by funds: $1.68B | Put options by funds: $2.33B
Holders
1,515
Holding in Top 10
89
Calls
$1.68B
Puts
$2.33B
Top Buyers
1 | +$261M | |
2 | +$249M | |
3 | +$194M | |
4 |
Renaissance Technologies
New York
|
+$191M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$152M |
Top Sellers
1 | -$640M | |
2 | -$235M | |
3 | -$225M | |
4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$171M |
5 |
State Street
Boston,
Massachusetts
|
-$134M |